Longitudinal assessment of hematopoietic abnormalities after autologous hematopoietic cell transplantation for lymphoma.

@article{Bhatia2005LongitudinalAO,
  title={Longitudinal assessment of hematopoietic abnormalities after autologous hematopoietic cell transplantation for lymphoma.},
  author={Ravi Bhatia and Khristine Van Heijzen and Ann T Palmer and Asako Komiya and Marilyn L. Slovak and Karen L Chang and Henry Hoi Tai Fung and Amrita Y. Krishnan and Arturo Molina and Auayporn P. Nademanee and Margaret O'donnell and Leslie L Popplewell and Roberto R Rodr{\'i}guez and Stephen J. Forman and Smita Bhatia},
  journal={Journal of clinical oncology : official journal of the American Society of Clinical Oncology},
  year={2005},
  volume={23 27},
  pages={6699-711}
}
PURPOSE Autologous hematopoietic cell transplantation (HCT) is being increasingly used as an effective treatment strategy for patients with relapsed or refractory Hodgkin's lymphoma (HL) or non-Hodgkin's lymphoma (NHL) but is associated with therapy-related myelodysplasia and acute myeloid leukemia (t-MDS/AML) as a major cause of nonrelapse mortality. The phenomenon of hematopoietic reconstitution after autologous HCT and the role of proliferative stress in the pathogenesis of t-MDS/AML are… CONTINUE READING

Citations

Publications citing this paper.
Showing 1-10 of 23 extracted citations

Therapy-related myelodysplastic syndrome.

Expert opinion on drug safety • 2015
View 4 Excerpts
Highly Influenced

Aging impairs long-term hematopoietic regeneration after autologous stem cell transplantation.

Biology of blood and marrow transplantation : journal of the American Society for Blood and Marrow Transplantation • 2014

Similar Papers

Loading similar papers…